David N Neubauer

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. ncbi request reprint Understanding insomnia: Diagnosis and management of a common sleep disorder
    Joseph A Lieberman
    Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA, USA
    J Fam Pract 56:35A-49A; quiz 50A. 2007
  2. ncbi request reprint Chronic insomnia: current issues
    David N Neubauer
    The Johns Hopkins School of Medicine, Department of Psychiatry, The Johns Hopkins Sleep Disorders Center, Baltimore, Maryland 21224, USA
    Clin Cornerstone 6:S17-22. 2004
  3. ncbi request reprint Insomnia
    David N Neubauer
    Department of Pyschiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD 21287 7413, USA
    Prim Care 32:375-88. 2005
  4. pmc The evolution and development of insomnia pharmacotherapies
    David N Neubauer
    Sleep Disorders Center Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Clin Sleep Med 3:S11-5. 2007
  5. ncbi request reprint Almorexant, a dual orexin receptor antagonist for the treatment of insomnia
    David N Neubauer
    Johns Hopkins Bayview Medical Center, Department of Psychiatry, 4940 Eastern Avenue, Box 151, Baltimore, MD 21224, USA
    Curr Opin Investig Drugs 11:101-10. 2010
  6. doi request reprint Tasimelteon for the treatment of non-24-hour sleep-wake disorder
    D N Neubauer
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Drugs Today (Barc) 51:29-35. 2015
  7. pmc A review of ramelteon in the treatment of sleep disorders
    David N Neubauer
    Department of Psychiatry, Johns Hopkins University School of Medicine
    Neuropsychiatr Dis Treat 4:69-79. 2008
  8. pmc ZolpiMistâ„¢: a new formulation of zolpidem tartrate for the short-term treatment of insomnia in the US
    David N Neubauer
    Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Nat Sci Sleep 2:79-84. 2010
  9. doi request reprint Chronic insomnia
    David N Neubauer
    Johns Hopkins Bayview Medical Center, 4940 Eastern Ave, Box 151, Baltimore, MD 21224, USA
    Continuum (Minneap Minn) 19:50-66. 2013
  10. ncbi request reprint Current and new thinking in the management of comorbid insomnia
    David N Neubauer
    Johns Hopkins Sleep Disorders Center, 4940 Eastern Ave, Box 151, Baltimore, MD 21224, USA
    Am J Manag Care 15:S24-32. 2009

Detail Information

Publications19

  1. ncbi request reprint Understanding insomnia: Diagnosis and management of a common sleep disorder
    Joseph A Lieberman
    Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA, USA
    J Fam Pract 56:35A-49A; quiz 50A. 2007
  2. ncbi request reprint Chronic insomnia: current issues
    David N Neubauer
    The Johns Hopkins School of Medicine, Department of Psychiatry, The Johns Hopkins Sleep Disorders Center, Baltimore, Maryland 21224, USA
    Clin Cornerstone 6:S17-22. 2004
    ..An understanding of the characteristics and causes of this disorder and the available therapeutic strategies will promote more effective identification and treatment of patients with chronic insomnia...
  3. ncbi request reprint Insomnia
    David N Neubauer
    Department of Pyschiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD 21287 7413, USA
    Prim Care 32:375-88. 2005
    ..The effective treatment of insomnia can have further benefits in decreasing the likelihood of future psychiatric symptoms...
  4. pmc The evolution and development of insomnia pharmacotherapies
    David N Neubauer
    Sleep Disorders Center Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Clin Sleep Med 3:S11-5. 2007
  5. ncbi request reprint Almorexant, a dual orexin receptor antagonist for the treatment of insomnia
    David N Neubauer
    Johns Hopkins Bayview Medical Center, Department of Psychiatry, 4940 Eastern Avenue, Box 151, Baltimore, MD 21224, USA
    Curr Opin Investig Drugs 11:101-10. 2010
    ..The use of an orexin receptor antagonist for the treatment of sleep disorders appears to be an approach that may provide unique benefits...
  6. doi request reprint Tasimelteon for the treatment of non-24-hour sleep-wake disorder
    D N Neubauer
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Drugs Today (Barc) 51:29-35. 2015
    ..Safety studies in blind individuals diagnosed with non-24 are ongoing and a future clinical trial with Smith-Magenis syndrome patients is planned. ..
  7. pmc A review of ramelteon in the treatment of sleep disorders
    David N Neubauer
    Department of Psychiatry, Johns Hopkins University School of Medicine
    Neuropsychiatr Dis Treat 4:69-79. 2008
    ..Drug Enforcement Agency as a controlled substance. It is available as an 8 mg tablet, which should be taken approximately 30 minutes prior to bedtime. The FDA approval contains no limitation on how long the medication may be prescribed...
  8. pmc ZolpiMistâ„¢: a new formulation of zolpidem tartrate for the short-term treatment of insomnia in the US
    David N Neubauer
    Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Nat Sci Sleep 2:79-84. 2010
    ..ZolpiMist is being investigated for the possible indication of use during middle-of-the-night awakenings when the patient has at least 4 hours available to remain in bed...
  9. doi request reprint Chronic insomnia
    David N Neubauer
    Johns Hopkins Bayview Medical Center, 4940 Eastern Ave, Box 151, Baltimore, MD 21224, USA
    Continuum (Minneap Minn) 19:50-66. 2013
    ..This article provides an overview of current strategies for evaluating and treating patients who experience chronic insomnia...
  10. ncbi request reprint Current and new thinking in the management of comorbid insomnia
    David N Neubauer
    Johns Hopkins Sleep Disorders Center, 4940 Eastern Ave, Box 151, Baltimore, MD 21224, USA
    Am J Manag Care 15:S24-32. 2009
    ....
  11. ncbi request reprint Does modafinil safely and effectively treat shift-work sleep disorder?
    David N Neubauer
    Johns Hopkins Sleep Disorders Center, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
    Nat Clin Pract Neurol 2:134-5. 2006
  12. ncbi request reprint Indiplon: the development of a new hypnotic
    David N Neubauer
    Johns Hopkins Bayview Medical Center, 4940 Eastern Avenue, Baltimore, MD 21224, USA
    Expert Opin Investig Drugs 14:1269-76. 2005
    ..The major challenge will be developing a commercial success in the crowded insomnia treatment marketplace...
  13. ncbi request reprint Pharmacologic approaches for the treatment of chronic insomnia
    David N Neubauer
    Johns Hopkins School of Medicine, Department of Psychiatry, Johns Hopkins Sleep Disorders Center, Baltimore, Maryland, USA
    Clin Cornerstone 5:16-27. 2003
    ..This article reviews the advantages and disadvantages of medications and other substances employed to promote improved sleep. Special emphasis is given to the use of the newer-generation benzodiazepine receptor agonist hypnotics...
  14. doi request reprint Chronic insomnia
    David N Neubauer
    Johns Hopkins Sleep Disorders Center, Johns Hopkins Bayview Medical Center, Baltimore, Maryland 21224, USA
    Semin Neurol 29:340-53. 2009
    ..Treatment of chronic insomnia can make a significant improvement in quality of life, and may also be associated with an improvement in comorbid conditions...
  15. ncbi request reprint Cognitive behavior therapy for chronic insomnia
    Michael T Smith
    Johns Hopkins School of Medicine, Department of Psychiatry, Behavioral Medicine Research Laboratory and Clinic, Baltimore, Maryland, USA
    Clin Cornerstone 5:28-40. 2003
    ....
  16. pmc Sleep disturbance in heavy marijuana users
    Karen I Bolla
    Department of Neurology, Johns Hopkins Medical Institutions, Bayview Medical Center, Baltimore, MD 21224, USA
    Sleep 31:901-8. 2008
    ..To determine if recently abstinent, heavy marijuana (MJ) users show differences in polysomnographic (PSG) measures compared with a drug-free control group...
  17. ncbi request reprint The association between daytime sleepiness and sleep-disordered breathing in NREM and REM sleep
    Naresh M Punjabi
    Sleep 25:307-14. 2002
    ....
  18. ncbi request reprint State-of-the-art sleep management
    David N Neubauer
    Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, USA
    Manag Care 15:6-12, 17. 2006
  19. pmc Polysomnogram changes in marijuana users who report sleep disturbances during prior abstinence
    Karen I Bolla
    Department of Neurology, Johns Hopkins Medical Institutions, Bayview Medical Center, Baltimore, MD 21224, USA
    Sleep Med 11:882-9. 2010
    ..Few studies have used polysomnography (PSG) to characterize changes in sleep architecture during abrupt abstinence from heavy MJ use...